CDC reported US overdose death trends and expanding naloxone access, while Emergent BioSolutions acquired rights to KLOXXADO in Canada.
1 report, 0 independent
Updated Jul 3
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
CDC reported US overdose death trends and expanding naloxone access, while Emergent BioSolutions acquired rights to KLOXXADO in Canada.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Emergent BioSolutions is facing increased competition and pricing pressure in the naloxone market while undergoing restructuring and accelerating government deliveries.Sub-event
- US overdose trends reported; naloxone access expanding and KLOXXADO rights acquired in Canada.
Keep exploring
The entities involved
-
Centers for Disease Control and Prevention
government organization in Kampala, Uganda
-
Emergent BioSolutions
multinational biopharmaceutical company headquartered in Gaithersburg, Maryland, USA
Related events
Coverage
Newest first; wire copies grouped- Unknown outlet